80 Participants Needed

Lifestyle Intervention for Obesity

MM
JL
Overseen ByJessica LaRose
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Virginia Commonwealth University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Do I have to stop taking my current medications?

The trial protocol does not specify if you need to stop taking your current medications. However, if you are currently using weight loss medication, you cannot participate in the trial.

What data supports the idea that Lifestyle Intervention for Obesity is an effective treatment?

The available research shows that Lifestyle Intervention for Obesity can lead to significant weight loss. For example, one study found that people who completed the program lost an average of 8-10% of their initial body weight in about 30 weeks. Another study reported an average weight loss of 10 kg by the end of a short-term program, with some weight still lost after a year. These results suggest that the treatment is effective in helping people lose weight. Additionally, lifestyle interventions have been shown to improve quality of life and reduce health risks associated with obesity. Compared to other methods, such as Internet-based programs, on-site lifestyle interventions tend to result in greater weight loss. Overall, these findings indicate that lifestyle interventions are a promising approach for managing obesity.12345

What safety data exists for the lifestyle intervention for obesity?

The provided research abstracts do not specifically mention safety data for the lifestyle intervention for obesity. They focus on the effectiveness, challenges, and implementation of lifestyle interventions for weight loss and obesity management. To find specific safety data, further detailed studies or clinical trial reports would be needed.15678

Is the 12-week lifestyle intervention a promising treatment for obesity?

Yes, the 12-week lifestyle intervention is promising for treating obesity. It helps people adopt healthier habits, like better eating and more exercise, which can lead to weight loss and improved health. Studies show that lifestyle changes can be effective in managing obesity and can be adapted to fit different people's needs.158910

What is the purpose of this trial?

African American adults that live in economically disadvantaged areas are at an increased risk for obesity and cardiometabolic disease. The treatment program being tested in this research study aims to address these factors and increase outcomes for the study population. The purpose of this research study is to find out about the feasibility and acceptability of using house chats (HC) as a model for a weight loss program in a real-world, community-based setting.

Research Team

MM

Moghboeba Mosavel

Principal Investigator

Virginia Commonwealth University

Eligibility Criteria

This trial is for African American adults who are at least 18 years old and live in Petersburg, VA. It's designed to help those living in economically disadvantaged areas reduce obesity and improve heart health through a community-based program.

Inclusion Criteria

You live in Petersburg, VA.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a 12-week lifestyle intervention delivered via weekly group meetings in the HCL's homes

12 weeks
Weekly group meetings

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 12 and 24 weeks post-treatment

12 weeks
In-person assessment visits at 12 and 24 weeks

Long-term follow-up

Mixed methods approach to assess factors that might promote and/or interfere with sustainability over long-term follow-up

Treatment Details

Interventions

  • 12-week lifestyle intervention
Trial Overview The study is testing a 12-week lifestyle intervention that includes 'house chats' as a method of delivering weight loss coaching. The goal is to see if this approach is practical and well-received in the community setting.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants will be randomized to intervention and will receive the 12-week program.
Group II: Delayed Intervention ControlActive Control1 Intervention
Participants will be randomized to delayed intervention control and will receive the same 12-week program.

12-week lifestyle intervention is already approved in United States for the following indications:

🇺🇸
Approved in United States as 12-week lifestyle intervention for:
  • Weight loss
  • Obesity prevention
  • Cardiometabolic disease prevention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Virginia Commonwealth University

Lead Sponsor

Trials
732
Recruited
22,900,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+

Findings from Research

Lifestyle modification therapy can lead to a significant weight loss of 8-10% over approximately 30 weeks for overweight and obese patients, combining diet, exercise, and behavioral strategies.
To enhance the effectiveness and sustainability of this therapy, new strategies such as individualized treatment, remote delivery via phone or internet, and integration with community programs or bariatric surgery have shown promising results.
Lifestyle modification in the management of obesity: achievements and challenges.Dalle Grave, R., Calugi, S., El Ghoch, M.[2022]
Short-term behavioral interventions for obesity typically result in an average weight loss of 10 kg during the program and 6.6 kg at one year follow-up, indicating some effectiveness in the short term.
To improve long-term weight management, a chronic disease model of obesity treatment is suggested, emphasizing the need for ongoing care and potentially incorporating highly structured diets and supervised exercise.
Behavioral treatment of severe obesity.Wing, RR.[2018]
A 10-14 week inpatient intensive lifestyle intervention (ILI) for 100 severely obese individuals led to significant improvements in quality of life, including reductions in binge eating, anxiety, and depression, as well as enhancements in physical and mental health.
The study found that improvements in binge eating and physical health were directly associated with weight loss, indicating that the ILI not only helped participants lose weight but also positively impacted their overall well-being.
Beyond weight reduction: improvements in quality of life after an intensive lifestyle intervention in subjects with severe obesity.Danielsen, KK., Sundgot-Borgen, J., Mæhlum, S., et al.[2015]

References

Lifestyle modification in the management of obesity: achievements and challenges. [2022]
Behavioral treatment of severe obesity. [2018]
Beyond weight reduction: improvements in quality of life after an intensive lifestyle intervention in subjects with severe obesity. [2015]
Lifestyle modification for the management of obesity. [2022]
Behavior therapy for obesity: where are we now? [2022]
Randomized trial of a novel lifestyle intervention compared with the Diabetes Prevention Program for weight loss in adult dependents of military service members. [2023]
Development of an online diabetes prevention lifestyle intervention coaching protocol for use in primary care practice. [2018]
Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition (ICAN) study. [2019]
The implementation of the coaching on lifestyle (CooL) intervention: lessons learnt. [2020]
Prevention and treatment of obesity with lifestyle interventions: review and meta-analysis. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security